As we explained above, BMPs have been shown to promote GIC differentiation and to reduce GBM proliferation in vitro and in vivo [23, 24, 29–31, 38], so they are becoming promising therapeutic tools that could be used in combination with other conventional treatments (Figure 1). Here, CLN5 is linked to glioblastoma.